ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

March 3, 1989

Radiosensitizer Screen Concept OK’d, Acoustic Microscopy Delayed

March 2, 1990

Carcinogenesis, Epidemiology, Smoking RFAs Get DCCP Board Okay

June 12, 1981

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

Surgeons, Intramural Scientists Concerned About Representation

November 26, 1976